Total Credits: 2 including 2 AOA Category 1-A Credit(s)
The Effects of Climate Change on our Health
This session will provide an overview about climate change and a discussion regarding how it affecting the health of our patients as well as solutions to improve climate health.
Upon completion of this program, participants will be able to:
The Opioid Epidemic and Social Determinants of Health (Opioid)
This session provides an overview of the opioid epidemic and the reasons behind it. Between demand and supply of opioids, supply has always been emphasized. Controlling supply by tighter prescribing and dispensing policies, as well as stricter regulatory and professional guidelines was unable to decrease opioid-related overdose deaths. In this presentation, we explore social determinants of health, the primarily overlooked player in the development of the opioid epidemic, and the role they play in susceptibility to substance use, access to appropriate pain management, overdose emergency care and addiction treatment programs, as well as the success of these programs.
Upon completion of this program, participants will be able to:
Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates is program for a maximum of 2 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.
Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| edwards_am22 handout (1.98 MB) | Available after Purchase | ||
| edwards_am22 handout2 (0.16 MB) | Available after Purchase | ||
| soliman handouts_am22_updated.pdf (6.1 MB) | Available after Purchase | ||
Dr. Jessica Edwards is practicing family medicine in New Braunfels, Texas, and earned her master of science degree from the HSC’s Graduate School of Biomedical Sciences in 2010. She is board certified in Family Medicine and OMT by the American Osteopathic Board of Family Physicians.
She completed her residency at Care Point Health in Family Medicine in Jersey City, New Jersey. In 2016, she was the recipient of the American Osteopathic Foundation/American College of Osteopathic Family Physicians Outstanding Resident in Family Medicine Award.
She was selected and served on AACOM’s prestigious Osteopathic Health Policy Fellowship. She received the National Medicine Association Post Graduate Top Healthcare Professional Under 40 Award in 2019. In 2020, she was a keynote speaker at the TOMA Midwinter Conference. She is the Founder and CEO of Zara Medical Aesthetics and is currently practicing Family Medicine.
Dr. Edwards discloses that she has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
Dr. Sahar Soliman is an Assistant Professor of Pharmacology at the College of Osteopathic Medicine, Sam Houston State University. Her pharmacy training and her passion to promote safe medication practices in rural and underserved areas led her to conduct rural health-centered research studying the opioid crisis, with an emphasis on rural communities of East Texas. Dr. Soliman is conducting her research with a multidisciplinary team from the College of Osteopathic Medicine and Sam Houston State University. Her current research in this field includes identifying opioid use patterns in East Texas and the influence of social determinants of health on the opioid crisis. Her most recent research work focuses on studying the effect of the COVID-19 pandemicon the opioid epidemic in the State of Texas.
Dr. Soliman obtained her pharmacy degree from the College of Pharmacy, Ain Shams University in Cairo, Egypt and obtained her PhD in Clinical and experimental therapeutics from the College of Pharmacy, University of Georgia in Augusta, Georgia. Her doctoral training focused on the neurovascular unit, with the goal of repurposing FDA-approved medications for stroke therapy. Her postdoctoral research at Yale School of Medicine, New Haven, Connecticut focused on studying the role of pericytes in intraventricular hemorrhage of prematurity.
Dr. Soliman discloses that she has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|